OPIANT PHARMACEUTICALS, INC. — Net Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/17628f33-b333-4e17-b614-008433713c03/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $3.0M | 2021-01-01 – 2021-12-31 | evidence 0001385508-22-000038 |
| FY 2020 | $-1.9M | 2020-01-01 – 2020-12-31 | evidence 0001385508-21-000035 |
| FY 2019 | $11.6M | 2019-01-01 – 2019-12-31 | evidence 0001385508-20-000039 |
| FY 2018 | $-21.2M | 2018-01-01 – 2018-12-31 | evidence 0001385508-19-000028 |
| FY 2017 | $-2.6M | 2017-01-01 – 2017-12-31 | evidence 0001385508-19-000028 |
| FY 2016 | $-7.8M | 2015-08-01 – 2016-07-31 | evidence 0001144204-16-130283 |
| FY 2015 | $-7.0M | 2014-08-01 – 2015-07-31 | evidence 0001144204-15-060795 |
| FY 2014 | $-11.5M | 2013-08-01 – 2014-07-31 | evidence 0001144204-14-063064 |
| FY 2013 | $-42.2M | 2005-06-21 – 2014-04-30 | evidence 0001144204-14-036713 |
| FY 2012 | $-26.7M | 2005-06-21 – 2013-04-30 | evidence 0001144204-13-035032 |
| FY 2011 | $-22.3M | 2005-06-21 – 2012-04-30 | evidence 0001185185-12-001341 |
| FY 2010 | $-2.0M | 2009-08-01 – 2010-07-31 | evidence 0001185185-11-002229 |
| FY 2009 | $28.4k | 2008-08-01 – 2009-07-31 | evidence 0001185185-11-002229 |
| FY 2008 | $-17.9k | 2007-08-01 – 2008-07-31 | evidence 0001185185-11-002229 |
| FY 2007 | $-33.6k | 2006-08-01 – 2007-07-31 | evidence 0001185185-11-002229 |
| FY 2006 | $-32.1k | 2005-08-01 – 2006-07-31 | evidence 0001185185-11-002229 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
OPIANT PHARMACEUTICALS, INC. — all facts · Revenue · Operating Income